Improvement of Care and Outcome

An important goal for Diabeter is to optimize the outcome for every patient, and minimize the burden of the disease. Our use of an electronic disease management system developed in-house (VCare) for over 15 years means that we have collected a vast amount of data, as well as experience. Rigorous scientific analyses of our datasets makes it possible for us to identify factors associated with better outcomes, and improve the care that we deliver.

 

As new medicines and new technologies enter the real world, we can make use of the VCare system to continually evaluate their impact on the management of T1DM. We can provide useful data on usability, efficacy, safety, and cost-effectiveness.

 

Our work in the field of outcomes research has included:

  • Identifying factors associated with the successful use of insulin pumps and continuous glucose sensors.
  • Investigating the use, impact, and outcome of new forms of treatment and patient-doctor communication, such as our ‘Ther@piemail’ (personalized e-mails with advice based on VCare-algorithms which is checked by HCPs).
  • Analyzing data for screening and treatment of concomitant diseases such as hypothyroidism and celiac disease.
  • Testing new insulin analogues such as insulin degludec (Tresiba).
  • Testing co-medications such as GLP-1 analogues.
  • Intervention studies with vaccines (Diagnode study) or immune-modulators (Diabil study) that should inhibit beta-cell destruction in T1DM.

 

Through research such as this, we can help refine and optimize treatment and its outcomes, developing the most appropriate personalized care for each patient. You can find our projects on these topics by clicking here or on the Projects button. 

© 2019 Diabeter | Terms of Use | Privacy Statement